TR200201087T2 - Doğrudan sıkıştırmalı polimer tablet - Google Patents

Doğrudan sıkıştırmalı polimer tablet

Info

Publication number
TR200201087T2
TR200201087T2 TR2002/01087T TR200201087T TR200201087T2 TR 200201087 T2 TR200201087 T2 TR 200201087T2 TR 2002/01087 T TR2002/01087 T TR 2002/01087T TR 200201087 T TR200201087 T TR 200201087T TR 200201087 T2 TR200201087 T2 TR 200201087T2
Authority
TR
Turkey
Prior art keywords
aliphatic amine
amine polymer
tablet
weight
direct compression
Prior art date
Application number
TR2002/01087T
Other languages
English (en)
Inventor
Tyler Joseph
S.Petersen John
Original Assignee
Geltex Pharmaceuticals,Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geltex Pharmaceuticals,Inc. filed Critical Geltex Pharmaceuticals,Inc.
Publication of TR200201087T2 publication Critical patent/TR200201087T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Mevcut bulus, agirlik olarak en az yaklasik %95 alifatik amin polimer içeren bir tablet saglar.Bulus ayni zamanda,agirlik olarak en az yaklasik %95 alifatik amin polimer reçine içeren bir tablet üretme yöntemi saglar. Yöntem,alifatik amin polimerin,tablet olusturmak üzere sikistirilmasi adimini içerir.Tablet ayrica bir veya daha fazla eksipiyan madde içerebilir. Bu düzenlemede,tablet üretme yöntemi su adimlari içerir: (1) alifatik amin polimerin hidratlanarak istenilen nemlilik seviyesine getirilmesi; (2) alifatik amin polimerin,polimer elde edilen karisimin agirlik olarak en az yaklasik %95'ini içerecek sekilde eksipiya madde miktarlariyla karistirilmasi; (3) karisimin sikistirilarak tabletlerin olusturulmasi.Mevcut bulus ayrica,kaplama maddesi su bazli olmak üzere,bir alifatik amin polimer çekirdek içeren kaplanmis bir tabletle ilgilidir.
TR2002/01087T 1999-10-19 2000-10-13 Doğrudan sıkıştırmalı polimer tablet TR200201087T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16025899P 1999-10-19 1999-10-19
US17422700P 2000-01-03 2000-01-03

Publications (1)

Publication Number Publication Date
TR200201087T2 true TR200201087T2 (tr) 2002-08-21

Family

ID=26856737

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01087T TR200201087T2 (tr) 1999-10-19 2000-10-13 Doğrudan sıkıştırmalı polimer tablet

Country Status (29)

Country Link
EP (1) EP1239837B1 (tr)
JP (4) JP4942271B2 (tr)
KR (1) KR100794427B1 (tr)
CN (1) CN1202812C (tr)
AR (1) AR026067A1 (tr)
AT (1) ATE286386T1 (tr)
AU (1) AU778262B2 (tr)
BG (1) BG106626A (tr)
BR (1) BRPI0015061B8 (tr)
CA (1) CA2387915C (tr)
CZ (1) CZ20021344A3 (tr)
DE (1) DE60017285T2 (tr)
EA (1) EA200200387A1 (tr)
EE (1) EE200200209A (tr)
ES (1) ES2235969T3 (tr)
HK (1) HK1049451B (tr)
HU (1) HUP0203334A2 (tr)
IL (1) IL149146A0 (tr)
IS (1) IS6343A (tr)
MX (1) MXPA02003684A (tr)
MY (1) MY125495A (tr)
NO (1) NO20021827L (tr)
NZ (1) NZ518334A (tr)
PL (1) PL364888A1 (tr)
PT (1) PT1239837E (tr)
SK (1) SK5412002A3 (tr)
TR (1) TR200201087T2 (tr)
TW (1) TWI225413B (tr)
WO (1) WO2001028527A2 (tr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1202812C (zh) * 1999-10-19 2005-05-25 基酶有限公司 直接压缩聚合物片剂核
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7449605B2 (en) 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
AU2004311849B2 (en) * 2003-12-31 2009-04-02 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
KR101269766B1 (ko) 2004-03-30 2013-05-30 리립사, 인크. 이온 결합 중합체 및 이의 용도
US7985418B2 (en) * 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
AU2012200480B2 (en) * 2004-11-01 2014-10-16 Genzyme Corporation "Aliphatic amine polymer salts for tableting"
MX2007011153A (es) * 2005-03-17 2007-12-12 Amgen Inc Metodos para reducir la calcificacion.
WO2007027566A2 (en) 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
CA2622693C (en) * 2005-09-15 2015-05-05 Genzyme Corporation Sachet formulation for amine polymers
WO2008062437A2 (en) * 2006-09-01 2008-05-29 Usv Limited Process for the preparation of sevelamer hydrochloride and formulation thereof
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
WO2009034540A1 (en) * 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Pharmaceutical composition of sevelamer
DE102008030046A1 (de) 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
KR20110059750A (ko) 2008-09-02 2011-06-03 유에스브이 리미티드 가교 폴리머
US20100330175A1 (en) * 2009-06-24 2010-12-30 Jobdevairakkam Christopher N Cross-linked polyallylamine tablet core
ES2350999B1 (es) * 2009-06-26 2011-12-07 Combino Pharm, S.L. Nueva composición farmacéutica comprendiendo hidrocloruro de poli (alilamin-co-n,n'-dialil-1,3-diamino-2-hidroxi propano).
WO2010149794A2 (en) 2009-06-26 2010-12-29 Combino Pharm, S.L. Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane)
WO2011047700A1 (en) * 2009-10-22 2011-04-28 Synthon B.V. Pharmaceutical compositions of sevelamer
EP2545907A1 (en) 2011-07-15 2013-01-16 Combino Pharm, S.L. Aqueous wet granulation process for cross-linked polyallylamine polymers
JP6289367B2 (ja) * 2012-06-05 2018-03-07 武田薬品工業株式会社 有核錠
CN102908325B (zh) * 2012-11-12 2014-07-30 南京生命能科技开发有限公司 一种碳酸司维拉姆药用片剂组合物及其制备方法
CN107412166B (zh) * 2017-08-08 2020-03-24 同济大学 一种纳米复合吸附磷材料及其制备与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2124736T3 (es) * 1991-07-03 1999-02-16 Upjohn Co Comprimidos con alto contenido de clorhidrato de colestipol.
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
JP3389493B2 (ja) * 1997-04-04 2003-03-24 中外製薬株式会社 リン酸結合性ポリマー製剤
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
US6083497A (en) * 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
TW568788B (en) * 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
CN1202812C (zh) * 1999-10-19 2005-05-25 基酶有限公司 直接压缩聚合物片剂核

Also Published As

Publication number Publication date
EE200200209A (et) 2003-06-16
NO20021827L (no) 2002-05-29
WO2001028527A2 (en) 2001-04-26
JP2003512317A (ja) 2003-04-02
PL364888A1 (en) 2004-12-27
KR100794427B1 (ko) 2008-01-16
NO20021827D0 (no) 2002-04-18
BRPI0015061B8 (pt) 2021-05-25
BG106626A (bg) 2003-03-31
NZ518334A (en) 2003-08-29
ES2235969T3 (es) 2005-07-16
AR026067A1 (es) 2002-12-26
JP2012067132A (ja) 2012-04-05
MY125495A (en) 2006-08-30
AU778262B2 (en) 2004-11-25
HK1049451A1 (en) 2003-05-16
MXPA02003684A (es) 2002-08-30
TWI225413B (en) 2004-12-21
CN1382041A (zh) 2002-11-27
HUP0203334A2 (hu) 2003-02-28
IL149146A0 (en) 2002-11-10
KR20020059629A (ko) 2002-07-13
BRPI0015061B1 (pt) 2016-03-22
JP4942271B2 (ja) 2012-05-30
CA2387915C (en) 2007-04-17
BR0015061A (pt) 2002-07-23
SK5412002A3 (en) 2002-09-10
JP5903111B2 (ja) 2016-04-13
EP1239837A2 (en) 2002-09-18
HK1049451B (zh) 2005-12-16
DE60017285D1 (de) 2005-02-10
CA2387915A1 (en) 2001-04-26
PT1239837E (pt) 2005-05-31
JP5583110B2 (ja) 2014-09-03
CN1202812C (zh) 2005-05-25
CZ20021344A3 (cs) 2002-08-14
AU1088701A (en) 2001-04-30
EP1239837B1 (en) 2005-01-05
EA200200387A1 (ru) 2002-10-31
JP2016000753A (ja) 2016-01-07
JP2014065749A (ja) 2014-04-17
DE60017285T2 (de) 2005-12-08
ATE286386T1 (de) 2005-01-15
WO2001028527A3 (en) 2002-01-03
IS6343A (is) 2002-04-15

Similar Documents

Publication Publication Date Title
EA200200387A1 (ru) Сердцевина таблетки, изготовленная из полимера способом прямого прессования
NO20002547D0 (no) Poly(vinylamin)-baserte superabsorberende geler og fremgangsmÕte for fremstilling derav
ATE238771T1 (de) Herstellungsverfahren von löslichen verabreichungssystemen unter verwendung von flüchtigen salzen
NO20101615L (no) Materiale for hemming av proliferasjon av celler, og fremgangsmate til fremstilling av samme, og anvendelse derav.
BRPI0410164A (pt) composições e métodos para preparação de mutantes de glicosilação de hormÈnio do crescimento humano
DE50115872D1 (de) Verfahren zur herstellung eines bioanalytischen reagenzes, nachweisverfahren beruhend auf der verwendung des bioanalytischen reagenz, sowie dessen verwendung
DE50110767D1 (de) Steinschlagschutzgrundierung, verfahren zu ihrer herstellung und ihre verwendung
ATE228828T1 (de) Verfahren zur herstellung von festen cyclodextrinhaltigen dosierungsformen
MX9202055A (es) Dispersiones de resina epoxi/poliamida curables, estables, de un solo componente.
TR200103556T2 (tr) Temizlik bileşimleri.
DE60006403D1 (de) In-situ herstellung einer polyasparaginsäureestermischung
WO2001032210A3 (en) Compositions for treating atheroma and neoplastic tissue
ATE305771T1 (de) Verfahren zur herstellung von vitaminpulvern
DE59905166D1 (de) Wasserlösliche sulfoalkylgruppenhaltige hydrophob modifizierte Celluloseether, Verfahren zu deren Herstellung sowie deren Verwendung als Schutzkolloide bei Polymerisationen
ATE24526T1 (de) Herstellung von photohaertbaren zusammensetzungen.
ES2176970T3 (es) Procedimiento para la obtencion de polimeros, que contienen unidades de carbamato, y su empleo.
ATE440608T1 (de) Zusammensetzungen aus lignin und verfahren zu ihrer herstellung und verwendung
TW200628543A (en) Method for producing branched polyether resin composition and method for producing acid pendant branched polyether resin composition
TR199800210T2 (tr) Didepsipeptid temelli endoparazitisid kompozisyonlar, yeni didepsipeptidler ve bunlarin üretimi için islemler.
MXPA03007415A (es) Emulsiones de resinas epoxidicas liquidas, metodo para la produccion y su uso.
JPS57158202A (en) Production of crown ether ring-containing polymer
DE19881543D2 (de) Gepreßte Chloramin T-Tabletten und Verfahren zu ihrer Herstellung
DK1149084T3 (da) Fremgangsmåde til fremstilling af L-ascorbinsyre
EP1044979A3 (en) 1-[(N-(un)substituted)amidoalkyl]spiroindolinonaphthoxazines, their preparation, compositions and (co)polymer matrices containing them
JPS5575421A (en) Epoxy resin composition